Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription Articles published in Cancer Lett Retrieve available abstracts of 88 articles: HTML format Text format

Single Articles

January 2019
1. JUNG PY, Ryu H, Rhee KJ, Hwang S, et al
   Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-beta and TRAIL and suppress the growth of H460 human lung cancer cells.
   Cancer Lett. 2019;440-441:202-210.
   PubMed     Text format     Abstract available
   
   
   November 2018
2. LUKIC A, Wahlund CJE, Gomez C, Brodin D, et al
   Exosomes and cells from lung cancer pleura exudates transform LTC4 to LTD4, promoting cell migration and survival via CysLT1.
   Cancer Lett. 2018 Nov 30. pii: S0304-3835(18)30699.
   PubMed     Text format     Abstract available
   
   
   
3. GU J, Mao W, Ren W, Xu F, et al
   Ubiquitin-protein Ligase E3C Maintains Non-small-cell Lung Cancer Stemness by Targeting AHNAK-p53 Complex.
   Cancer Lett. 2018 Nov 29. pii: S0304-3835(18)30695.
   PubMed     Text format     Abstract available
   
   
   
4. TREMBLE LF, O'Brien MA, Forde PF
   Electrochemotherapy with cisplatin increases survival and induces immunogenic responses in murine models of lung cancer and colorectal cancer.
   Cancer Lett. 2018 Nov 22. pii: S0304-3835(18)30680.
   PubMed     Text format     Abstract available
   
   
   
5. HUANG WT, Chong IW, Chen HL, Li CY, et al
   Pigment epithelium-derived factor inhibits lung cancer migration and invasion by upregulating exosomal thrombospondin 1.
   Cancer Lett. 2018 Nov 12. pii: S0304-3835(18)30646.
   PubMed     Text format     Abstract available
   
   
   October 2018
6. ZHANG P, Kang B, Xie G, Li S, et al
   Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer.
   Cancer Lett. 2018;442:53-67.
   PubMed     Text format     Abstract available
   
   
   
7. WANG Z, Fu S, Zhao J, Zhao W, et al
   Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancer.
   Cancer Lett. 2018 Oct 19. pii: S0304-3835(18)30628.
   PubMed     Text format     Abstract available
   
   
   September 2018
8. DI W, Yang B, Chen J, Xiong H, et al
   Upregulation of long non-coding RNA RAB1A-2 induces FGF1 expression worsening lung cancer prognosis.
   Cancer Lett. 2018 Sep 11. pii: S0304-3835(18)30571.
   PubMed     Text format     Abstract available
   
   
   August 2018
9. WANG Y, Wu L, Yao Y, Lu G, et al
   Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer.
   Cancer Lett. 2018;436:1-9.
   PubMed     Text format     Abstract available
   
   
   July 2018
10. CHIANG CT, Demetriou AN, Ung N, Choudhury N, et al
    mTORC2 contributes to the metabolic reprogramming in EGFR tyrosine-kinase inhibitor resistant cells in non-small cell lung cancer.
    Cancer Lett. 2018 Jul 20. pii: S0304-3835(18)30483.
    PubMed     Text format     Abstract available
    
    
    
11. ZHANG DL, Qu LW, Ma L, Zhou YC, et al
    Genome-wide identification of transcription factors that are critical to non-small cell lung cancer.
    Cancer Lett. 2018 Jul 18. pii: S0304-3835(18)30478.
    PubMed     Text format     Abstract available
    
    
    June 2018
12. LU Z, Li Y, Che Y, Huang J, et al
    The TGFbeta-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling.
    Cancer Lett. 2018;432:156-168.
    PubMed     Text format     Abstract available
    
    
    May 2018
13. LU T, Li Z, Yang Y, Ji W, et al
    Corrigendum to "The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer" [Canc. Lett. 423 (2018) 36-46].
    Cancer Lett. 2018 May 10. pii: S0304-3835(18)30275.
    PubMed     Text format    
    
    
    
14. HSU HY, Lin TY, Hu CH, Shu DTF, et al
    Fucoidan Upregulates TLR4/CHOP-Mediated Caspase-3 and PARP Activation to Enhance Cisplatin-Induced Cytotoxicity in Human Lung Cancer Cells.
    Cancer Lett. 2018 May 7. pii: S0304-3835(18)30325.
    PubMed     Text format     Abstract available
    
    
    April 2018
15. YU F, Liu JB, Wu ZJ, Xie WT, et al
    Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14.
    Cancer Lett. 2018 Apr 24. pii: S0304-3835(18)30289.
    PubMed     Text format     Abstract available
    
    
    
16. ZHAO X, Wu X, Qian M, Song Y, et al
    Knockdown of TGF-beta1 expression in human umbilical cord mesenchymal stem cells reverts their exosome-mediated EMT promoting effect on lung cancer cells.
    Cancer Lett. 2018 Apr 24. pii: S0304-3835(18)30293.
    PubMed     Text format     Abstract available
    
    
    
17. TAN W, Liao Y, Qiu Y, Liu H, et al
    miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP).
    Cancer Lett. 2018 Apr 24. pii: S0304-3835(18)30295.
    PubMed     Text format     Abstract available
    
    
    
18. JING P, Zhao N, Ye M, Zhang Y, et al
    Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
    Cancer Lett. 2018 Apr 18. pii: S0304-3835(18)30286.
    PubMed     Text format     Abstract available
    
    
    
19. YU X, Zhang Y, Ma X, Pertsemlidis A, et al
    miR-195 Potentiates the Efficacy of Microtubule-Targeting Agents in Non-Small Cell Lung Cancer.
    Cancer Lett. 2018 Apr 13. pii: S0304-3835(18)30268.
    PubMed     Text format     Abstract available
    
    
    
20. RODRIGUEZ-MARTINEZ A, Torres-Duran M, Barros-Dios JM, Ruano-Ravina A, et al
    Residential radon and small cell lung cancer. A systematic review.
    Cancer Lett. 2018 Apr 11. pii: S0304-3835(18)30264.
    PubMed     Text format     Abstract available
    
    
    
21. HU W, Bi ZY, Chen ZL, Liu C, et al
    Emerging landscape of circular RNAs in lung cancer.
    Cancer Lett. 2018 Apr 10. pii: S0304-3835(18)30267.
    PubMed     Text format     Abstract available
    
    
    March 2018
22. LE HT, Nguyen HT, Min HY, Hyun SY, et al
    Corrigendum to "Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells" [Canc. Lett. 412 (2018) 297-307].
    Cancer Lett. 2018 Mar 21. pii: S0304-3835(18)30220.
    PubMed     Text format    
    
    
    
23. CAO X, Zhou Y, Sun H, Xu M, et al
    EGFR-TKI-induced HSP70 degradation and BER suppression facilitate the occurrence of the EGFR T790M resistant mutation in lung cancer cells.
    Cancer Lett. 2018 Mar 7. pii: S0304-3835(18)30193.
    PubMed     Text format     Abstract available
    
    
    
24. ZHANG GN, Zhang YK, Wang YJ, Gupta P, et al
    Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo.
    Cancer Lett. 2018 Mar 5. pii: S0304-3835(18)30181.
    PubMed     Text format     Abstract available
    
    
    February 2018
25. YANG YF, Lee YC, Lo S, Chung YN, et al
    A positive feedback loop of IL-17B-IL-17RB activates ERK/beta-catenin to promote lung cancer metastasis.
    Cancer Lett. 2018;422:44-55.
    PubMed     Text format     Abstract available
    
    
    
26. GOU W, Zhou X, Liu Z, Wang L, et al
    CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib.
    Cancer Lett. 2018 Feb 22. pii: S0304-3835(18)30171.
    PubMed     Text format     Abstract available
    
    
    
27. LU T, Li Z, Yang Y, Ji W, et al
    The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer.
    Cancer Lett. 2018 Feb 13. pii: S0304-3835(18)30142.
    PubMed     Text format     Abstract available
    
    
    
28. SAIJO A, Goto H, Nakano M, Mitsuhashi A, et al
    Bone marrow-derived fibrocytes promote stem cell-like properties of lung cancer cells.
    Cancer Lett. 2018 Feb 12. pii: S0304-3835(18)30143.
    PubMed     Text format     Abstract available
    
    
    
29. TANG ZH, Lu JJ
    Osimertinib resistance in non-small cell lung cancer: Mechanisms and therapeutic strategies.
    Cancer Lett. 2018 Feb 6. pii: S0304-3835(18)30129.
    PubMed     Text format     Abstract available
    
    
    
30. ZHANG Y, Lin Q, Xu T, Deng W, et al
    Out of the darkness and into the light: New strategies for improving treatments for locally advanced non-small cell lung cancer.
    Cancer Lett. 2018 Feb 6. pii: S0304-3835(18)30128.
    PubMed     Text format     Abstract available
    
    
    
31. CHAI S, Qian Y, Tang J, Liang Z, et al
    Retraction notice to "Ca2+/Calmodulin-dependent protein kinase IIgamma, a critical mediator of the NF-kappaB network, is a novel therapeutic target in non-small cell lung cancer" [Cancer Lett. 344(1) (2014) 119-128].
    Cancer Lett. 2018;414:312.
    PubMed     Text format    
    
    
    
32. GRUNDEMANN C, Huber R
    Chemoprevention with isothiocyanates - From bench to bedside.
    Cancer Lett. 2018;414:26-33.
    PubMed     Text format     Abstract available
    
    
    January 2018
33. LI K, Sun D, Gou Q, Ke X, et al
    Long non-coding RNA linc00460 promotes epithelial-mesenchymal transition and cell migration in lung cancer cells.
    Cancer Lett. 2018 Jan 30. pii: S0304-3835(18)30093.
    PubMed     Text format     Abstract available
    
    
    
34. ZHANG Y, Zhang X, Ye M, Jing P, et al
    FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein.
    Cancer Lett. 2018 Jan 17. pii: S0304-3835(18)30069.
    PubMed     Text format     Abstract available
    
    
    
35. LI C, Wan L, Liu Z, Xu G, et al
    Long non-coding RNA XIST promotes TGF-beta-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
    Cancer Lett. 2018 Jan 12. pii: S0304-3835(18)30058.
    PubMed     Text format     Abstract available
    
    
    
36. WU D, Zhao B, Qi X, Peng F, et al
    Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway.
    Cancer Lett. 2018 Jan 10. pii: S0304-3835(18)30052.
    PubMed     Text format     Abstract available
    
    
    
37. WANG L, Syn NL, Subhash VV, Any Y, et al
    Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling.
    Cancer Lett. 2018 Jan 3. pii: S0304-3835(18)30003.
    PubMed     Text format     Abstract available
    
    
    
38. FU XT, Shi YH, Zhou J, Peng YF, et al
    MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma.
    Cancer Lett. 2018;412:108-117.
    PubMed     Text format     Abstract available
    
    
    December 2017
39. LEE JY, Talhi O, Jang D, Cerella C, et al
    Cytostatic hydroxycoumarin OT52 induces ER/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancer.
    Cancer Lett. 2017;416:94-108.
    PubMed     Text format     Abstract available
    
    
    
40. MAO Q, Jiang F, Yin R, Wang J, et al
    Interplay between the lung microbiome and lung cancer.
    Cancer Lett. 2017;415:40-48.
    PubMed     Text format     Abstract available
    
    
    
41. TESSEMA M, Yingling CM, Picchi MA, Wu G, et al
    ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.
    Cancer Lett. 2017;410:191-200.
    PubMed     Text format     Abstract available
    
    
    
42. YOSHIKAWA Y, Takano O, Kato I, Takahashi Y, et al
    Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1alpha pathway.
    Cancer Lett. 2017;410:82-91.
    PubMed     Text format     Abstract available
    
    
    November 2017
43. WANG J, Tian L, Khan MN, Zhang L, et al
    Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-kappaB mediated epithelial-mesenchymal transition and stemness.
    Cancer Lett. 2017 Nov 30. pii: S0304-3835(17)30762.
    PubMed     Text format     Abstract available
    
    
    
44. XUE X, Fei X, Hou W, Zhang Y, et al
    miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer.
    Cancer Lett. 2017;412:170-178.
    PubMed     Text format     Abstract available
    
    
    
45. JING L, Song F, Liu Z, Li J, et al
    MLKL-PITPalpha signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells.
    Cancer Lett. 2017 Nov 2. pii: S0304-3835(17)30693.
    PubMed     Text format     Abstract available
    
    
    October 2017
46. LIU X, Chen B, You W, Xue S, et al
    The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancer.
    Cancer Lett. 2017 Oct 23. pii: S0304-3835(17)30652.
    PubMed     Text format     Abstract available
    
    
    
47. LE HT, Nguyen HT, Min HY, Hyun SY, et al
    Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells.
    Cancer Lett. 2017 Oct 20. pii: S0304-3835(17)30648.
    PubMed     Text format     Abstract available
    
    
    
48. LI X, Ma T, Zhang Q, Chen YG, et al
    Modified-FOLFIRINOX in metastatic pancreatic cancer: A prospective study in Chinese population.
    Cancer Lett. 2017;406:22-26.
    PubMed     Text format     Abstract available
    
    
    
49. TANG ZH, Cao WX, Guo X, Dai XY, et al
    Identification of a novel autophagic inhibitor cepharanthine to enhance the anti-cancer property of dacomitinib in non-small cell lung cancer.
    Cancer Lett. 2017 Oct 9. pii: S0304-3835(17)30624.
    PubMed     Text format     Abstract available
    
    
    
50. TORRES-DURAN M, Ruano-Ravina A, Kelsey KT, Parente-Lamelas I, et al
    Environmental tobacco smoke exposure and EGFR and ALK alterations in never smokers' lung cancer. Results from the LCRINS study.
    Cancer Lett. 2017 Oct 5. pii: S0304-3835(17)30603.
    PubMed     Text format     Abstract available
    
    
    
51. YANG H, Lee MH, Park I, Jeon H, et al
    HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2.
    Cancer Lett. 2017;411:19-26.
    PubMed     Text format     Abstract available
    
    
    
52. BETTI M, Casalone E, Ferrante D, Aspesi A, et al
    Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
    Cancer Lett. 2017;405:38-45.
    PubMed     Text format     Abstract available
    
    
    September 2017
53. HUANG GX, Wang Y, Su J, Zhou P, et al
    Up-regulation of Rho-associated kinase 1/2 by glucocorticoids promotes migration, invasion and metastasis of melanoma.
    Cancer Lett. 2017 Sep 15. pii: S0304-3835(17)30552.
    PubMed     Text format     Abstract available
    
    
    
54. KIM SJ, Jung KH, Son MK, Park JH, et al
    Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery.
    Cancer Lett. 2017;403:339-353.
    PubMed     Text format     Abstract available
    
    
    
55. CHAN KK, Leung CO, Wong CC, Ho DW, et al
    Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway.
    Cancer Lett. 2017;403:330-338.
    PubMed     Text format     Abstract available
    
    
    
56. CAO L, Qi L, Zhang L, Song W, et al
    Human nonsense-mediated RNA decay regulates EMT by targeting the TGF-ss signaling pathway in lung adenocarcinoma.
    Cancer Lett. 2017;403:246-259.
    PubMed     Text format     Abstract available
    
    
    
57. LIU CH, Lan CT, Chou JF, Tseng TJ, et al
    CHSY1 promotes aggressive phenotypes of hepatocellular carcinoma cells via activation of the hedgehog signaling pathway.
    Cancer Lett. 2017;403:280-288.
    PubMed     Text format     Abstract available
    
    
    
58. LIANG Z, Cheng Y, Chen Y, Hu Y, et al
    EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIs.
    Cancer Lett. 2017;403:186-194.
    PubMed     Text format     Abstract available
    
    
    
59. WANG C, Zhou X, Li W, Li M, et al
    Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Cancer Lett. 2017;403:271-279.
    PubMed     Text format     Abstract available
    
    
    
60. ZHOU J, Zhang S, Chen X, Zheng X, et al
    Palbociclib, a selective CDK4/6 inhibitor, enhances the effect of selumetinib in RAS-driven non-small cell lung cancer.
    Cancer Lett. 2017 Sep 1. pii: S0304-3835(17)30518.
    PubMed     Text format     Abstract available
    
    
    August 2017
61. BAI Z, Gao M, Zhang H, Guan Q, et al
    BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Cancer Lett. 2017;402:81-92.
    PubMed     Text format     Abstract available
    
    
    
62. WANG ZQ, He CY, Hu L, Shi HP, et al
    Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer.
    Cancer Lett. 2017 Aug 23. pii: S0304-3835(17)30490.
    PubMed     Text format     Abstract available
    
    
    
63. ZHOU L, Lv T, Zhang Q, Zhu Q, et al
    The biology, function and clinical implications of exosomes in lung cancer.
    Cancer Lett. 2017 Aug 12. pii: S0304-3835(17)30480.
    PubMed     Text format     Abstract available
    
    
    
64. PARK KS, Yang H, Choi J, Seo S, et al
    The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer.
    Cancer Lett. 2017 Aug 7. pii: S0304-3835(17)30464.
    PubMed     Text format     Abstract available
    
    
    
65. PISANU ME, Noto A, De Vitis C, Morrone S, et al
    Blockade of Stearoyl-CoA-Desaturase 1 activity reverts resistance to Cisplatin in lung cancer stem cells.
    Cancer Lett. 2017 Aug 7. pii: S0304-3835(17)30463.
    PubMed     Text format     Abstract available
    
    
    
66. LI J, Tian H, Pan J, Jiang N, et al
    Pecanex functions as a competitive endogenous RNA of S-phase kinase associated protein 2 in lung cancer.
    Cancer Lett. 2017 Aug 5. pii: S0304-3835(17)30466.
    PubMed     Text format     Abstract available
    
    
    
67. YANG D, Cao X, Wang F, Jiang H, et al
    LFG-500, a novel synthetic flavonoid, suppresses epithelial-mesenchymal transition in human lung adenocarcinoma cells by inhibiting NLRP3 in inflammatory microenvironment.
    Cancer Lett. 2017;400:137-148.
    PubMed     Text format     Abstract available
    
    
    
68. WU J, He Z, Yang XM, Li KL, et al
    RCCD1 depletion attenuates TGF-beta-induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells.
    Cancer Lett. 2017;400:18-29.
    PubMed     Text format     Abstract available
    
    
    July 2017
69. TONG CWS, Wu WKK, Loong HHF, Cho WCS, et al
    Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer.
    Cancer Lett. 2017 Jul 31. pii: S0304-3835(17)30459.
    PubMed     Text format     Abstract available
    
    
    
70. STAPELFELD C, Neumann KT, Maser E
    Different inhibitory potential of sex hormones on NNK detoxification in vitro: a possible explanation for gender-specific lung cancer risk.
    Cancer Lett. 2017 Jul 22. pii: S0304-3835(17)30451.
    PubMed     Text format     Abstract available
    
    
    
71. MENG X, Liu Y, Zhang J, Teng F, et al
    PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges.
    Cancer Lett. 2017 Jul 6. pii: S0304-3835(17)30415.
    PubMed     Text format     Abstract available
    
    
    
72. GORZALCZANY Y, Akiva E, Klein O, Merimsky O, et al
    Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine/paracrine signaling of the adenosine A3 receptor.
    Cancer Lett. 2017;397:23-32.
    PubMed     Text format     Abstract available
    
    
    June 2017
73. BROCK M, Mei Y
    Protein functional effector sncRNAs (pfeRNAs) in lung cancer.
    Cancer Lett. 2017 Jun 19. pii: S0304-3835(17)30394.
    PubMed     Text format     Abstract available
    
    
    
74. DENG M, Zeng C, Lu X, He X, et al
    miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Cancer Lett. 2017 Jun 17. pii: S0304-3835(17)30387.
    PubMed     Text format     Abstract available
    
    
    
75. CHANG TH, Tsai MF, Gow CH, Wu SG, et al
    Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
    Cancer Lett. 2017;402:190-202.
    PubMed     Text format     Abstract available
    
    
    
76. CHANG YC, Chan YC, Chang WM, Lin YF, et al
    Feedback regulation of ALDOA activates the HIF-1alpha/MMP9 axis to promote lung cancer progression.
    Cancer Lett. 2017;403:28-36.
    PubMed     Text format     Abstract available
    
    
    
77. KWON OS, Hong SK, Kwon SJ, Go YH, et al
    BCL2 induced by LAMTOR3/MAPK is a druggable target of chemoradioresistance in mesenchymal lung cancer.
    Cancer Lett. 2017 Jun 10. pii: S0304-3835(17)30355.
    PubMed     Text format     Abstract available
    
    
    
78. DONG X, Liao W, Zhang L, Tu X, et al
    RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
    Cancer Lett. 2017 Jun 6. pii: S0304-3835(17)30370.
    PubMed     Text format     Abstract available
    
    
    
79. NERI S, Miyashita T, Hashimoto H, Suda Y, et al
    Fibroblast-led cancer cell invasion is activated by epithelial-mesenchymal transition through platelet-derived growth factor BB secretion of lung adenocarcinoma.
    Cancer Lett. 2017;395:20-30.
    PubMed     Text format     Abstract available
    
    
    May 2017
80. SILVA PM, Ribeiro N, Lima RT, Andrade C, et al
    Suppression of spindly delays mitotic exit and exacerbates cell death response of cancer cells treated with low doses of paclitaxel.
    Cancer Lett. 2017;394:33-42.
    PubMed     Text format     Abstract available
    
    
    
81. CHEN S, Dong Z, Yang P, Wang X, et al
    Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis.
    Cancer Lett. 2017;394:22-32.
    PubMed     Text format     Abstract available
    
    
    
82. CASTANON E, Soltermann A, Lopez I, Roman M, et al
    The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.
    Cancer Lett. 2017 May 24. pii: S0304-3835(17)30342.
    PubMed     Text format     Abstract available
    
    
    
83. ZHANG J, Kong L, Jiao Q, Li M, et al
    Stereotactic ablative radiotherapy in treatment of early-stage non-small cell lung cancer: Unsolved questions and frontiers ahead.
    Cancer Lett. 2017 May 16. pii: S0304-3835(17)30311.
    PubMed     Text format     Abstract available
    
    
    April 2017
84. WANG Y, Zhou Y, Tao F, Chai S, et al
    N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.
    Cancer Lett. 2017 Apr 26. pii: S0304-3835(17)30292.
    PubMed     Text format     Abstract available
    
    
    February 2017
85. SHEN CJ, Chan SH, Lee CT, Huang WC, et al
    Oleic acid-induced ANGPTL4 enhances head and neck squamous cell carcinoma anoikis resistance and metastasis via up-regulation of fibronectin.
    Cancer Lett. 2017;386:110-122.
    PubMed     Text format     Abstract available
    
    
    November 2016
86. KIM JY, Lee N, Kim YJ, Cho Y, et al
    Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.
    Cancer Lett. 2016 Nov 25. pii: S0304-3835(16)30710.
    PubMed     Text format     Abstract available
    
    
    
87. ZYSK A, DeNichilo MO, Panagopoulos V, Zinonos I, et al
    Adoptive transfer of ex vivo expanded Vgamma9Vdelta2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.
    Cancer Lett. 2016 Nov 16. pii: S0304-3835(16)30699.
    PubMed     Text format     Abstract available
    
    
    July 2016
88. KONG J, Sun W, Li C, Wan L, et al
    Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6.
    Cancer Lett. 2016;380:476-484.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: